DEFINITION
Hospital pharmacies should have a program/protocol to validate their processes internally, as well as their 3rd party suppliers to ensure drug consistency. Currently, quality is assumed but may not be demonstrated by the supplier of a drug(s). Certificates of Analysis and/or CQI (Continuous Quality Improvement) audits can be requested from the supplier to help validate the performance of the drug. If hospitals choose to utilize stability beyond USP guidelines, drug validation would be necessary for quality assurance within their batches.
DYNALABS APPROACH
DYNALABS testing protocols help validate your drug process is potent and sterile. Over time, our testing data will create a historical baseline which can demonstrate product consistency to maintain patient safety in your pharmacy. This can also support randomized audits to demonstrate quality and enforce a pedigree process within the pharmacy.